Clinical trial
Characterization of the Platelet and Immune Response in Adults Receiving SARS-CoV-2 Vaccine
NCT05171959 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of the Platelet and Immune Response in Adults Receiving SARS-CoV-2 Vaccine
- Lead sponsor
- University of Roma La Sapienza
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 5, 2021
- Completion date
- April 15, 2022
- Enrollment
- 32 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sars-cov-2 vaccination